EarningsQ2 2023 Earnings Report

United Therapeutics (UTHR) Q2 2023 Earnings Report

0 Followers

MX:UTHR Q2 2023 EPS Results

Actual EPS$95.17

Consensus EPS$82.98

Beat/MissBeat by +$12.19

One Year Ago EPS$43.77

Actual Revenue$10.83B

Expected Revenue$9.52B

Beat/MissBeat by +$1.31B

YoY Revenue Growth+27.76%

QuarterQ2 2023

Date08/02/2023

TimeBefore Open

Conference CallWednesday, August 2, 2023

MX:UTHR Upcoming Earnings

United Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:UTHR Q2 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	112.39 / -	130.042	―
Aug 05, 2026	2026 (Q2)	124.63 / 132.04	116.421	13.42% (+15.62)
May 06, 2026	2026 (Q1)	127.10 / 105.70	120.416	-12.22% (-14.71)
Feb 25, 2026	2025 (Q4)	129.50 / 139.85	112.425	24.39% (+27.43)
Oct 29, 2025	2025 (Q3)	132.89 / 130.04	116.057	12.05% (+13.98)
Jul 30, 2025	2025 (Q2)	132.49 / 116.42	106.25	9.57% (+10.17)
Apr 30, 2025	2025 (Q1)	121.61 / 120.42	112.062	7.46% (+8.35)
Feb 26, 2025	2024 (Q4)	116.24 / 112.42	79.188	41.97% (+33.24)
Oct 30, 2024	2024 (Q3)	118.47 / 116.06	97.713	18.77% (+18.34)
Jul 31, 2024	2024 (Q2)	118.15 / 106.25	95.171	11.64% (+11.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed